DB – 2022 R&D call series
Loading...
  • Mediaarrow_down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careersarrow_down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Loading...
  • Global United States
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
  • Home
  • Companyarrow_down
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Sciencearrow_down
      < Back
    • Science
    • Areas of focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibilityarrow_down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Contributions 
  • Patientsarrow_down
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
  1. Home
  2. Untitled
  3. Other Investor Event events

DB – 2022 R&D call series

Back

Post navigation

Previous
Next

DB – 2022 R&D call series

DB – 2022 R&D call series

- 27 June 2022 - 0 mins read
DB – 2022 R&D call series

Post navigation

Previous
Next

Share this on social media

  • Share on LinkedIn
  • Share on Twitter
  • Share on Facebook

Related Events

Oddo BHF Forum, Lyon (Management)
06 January 2023 0 mins read

Oddo BHF Forum, Lyon (Management)
Citi European bus tour, Paris
29 September 2022 0 mins read

Citi European bus tour, Paris
Goldman Sachs bus tour, Paris
23 September 2022 0 mins read

Goldman Sachs bus tour, Paris
Credit Suisse bus tour, Paris
21 September 2022 0 mins read

Credit Suisse bus tour, Paris
Capital Markets Day
17 May 2022 0 mins read

Capital Markets Day

IPN price

€110.10

 €2.50 (2.32%)

  • Media
  • Investors
  • Partnering
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Contact us
Latest_Ipsen logo
LinkedIn Twitter Facebook Instagram Youtube
  • Terms of Use
  • Cookies
  • Privacy
  • Compliance
  • Vigilance Alert: Identity Theft
  • U.S. Price Disclosures

Copyright © Ipsen Biopharmaceuticals, Inc. MP-US-000472. All rights reserved - 2024

You are now leaving the Ipsen US website. To continue, please click on continue.